GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » National Research Corp (NAS:NRC) » Definitions » Cyclically Adjusted FCF per Share

National Research (National Research) Cyclically Adjusted FCF per Share : $1.36 (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is National Research Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

National Research's adjusted free cash flow per share for the three months ended in Mar. 2024 was $0.330. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $1.36 for the trailing ten years ended in Mar. 2024.

During the past 12 months, National Research's average Cyclically Adjusted FCF Growth Rate was 2.30% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -1.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -2.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was -2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of National Research was 36.70% per year. The lowest was -4.00% per year. And the median was -0.10% per year.

As of today (2024-05-18), National Research's current stock price is $31.00. National Research's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $1.36. National Research's Cyclically Adjusted Price-to-FCF of today is 22.79.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of National Research was 47.36. The lowest was 7.51. And the median was 25.36.


National Research Cyclically Adjusted FCF per Share Historical Data

The historical data trend for National Research's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Research Cyclically Adjusted FCF per Share Chart

National Research Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.46 1.39 1.30 1.30 1.33

National Research Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.31 1.33 1.32 1.33 1.36

Competitive Comparison of National Research's Cyclically Adjusted FCF per Share

For the Health Information Services subindustry, National Research's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


National Research's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, National Research's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where National Research's Cyclically Adjusted Price-to-FCF falls into.



National Research Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, National Research's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.33/131.7762*131.7762
=0.330

Current CPI (Mar. 2024) = 131.7762.

National Research Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.219 100.560 0.287
201409 0.349 100.428 0.458
201412 0.211 99.070 0.281
201503 0.033 99.621 0.044
201506 0.276 100.684 0.361
201509 0.203 100.392 0.266
201512 0.261 99.792 0.345
201603 0.134 100.470 0.176
201606 0.233 101.688 0.302
201609 0.241 101.861 0.312
201612 0.321 101.863 0.415
201703 0.271 102.862 0.347
201706 0.060 103.349 0.077
201709 0.381 104.136 0.482
201712 0.211 104.011 0.267
201803 0.272 105.290 0.340
201806 0.305 106.317 0.378
201809 0.214 106.507 0.265
201812 0.439 105.998 0.546
201903 0.242 107.251 0.297
201906 0.299 108.070 0.365
201909 0.455 108.329 0.553
201912 0.416 108.420 0.506
202003 0.192 108.902 0.232
202006 0.294 108.767 0.356
202009 0.370 109.815 0.444
202012 0.571 109.897 0.685
202103 0.513 111.754 0.605
202106 0.374 114.631 0.430
202109 0.301 115.734 0.343
202112 0.405 117.630 0.454
202203 0.226 121.301 0.246
202206 0.336 125.017 0.354
202209 0.244 125.227 0.257
202212 0.248 125.222 0.261
202303 0.184 127.348 0.190
202306 0.182 128.729 0.186
202309 0.217 129.860 0.220
202312 0.323 129.419 0.329
202403 0.330 131.776 0.330

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


National Research  (NAS:NRC) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

National Research's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=31.00/1.36
=22.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of National Research was 47.36. The lowest was 7.51. And the median was 25.36.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


National Research Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of National Research's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


National Research (National Research) Business Description

Traded in Other Exchanges
N/A
Address
1245 Q Street, Lincoln, NE, USA, 68508
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. It operates in the United States and Canada, of which key revenue is derived from the United States.
Executives
Amandla Mk Trust 10 percent owner C/O THE BRYN MAWR TRUST COMPANY OF DELAW, 20 MONTCHANIN RD, SUITE 100, GREENVILLE DE 19807
Common Property Trust 10 percent owner 709 PIER 2, LINCOLN NE 68528
Parul Bhandari director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Stephen H Lockhart director C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Penny Ann Wheeler director C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Donald M Berwick director C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Jona S Raasch officer: Vice President and COO
Kevin R Karas officer: SVP Finance, CFO, Treas & Secy C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Michael & Karen Hays Grandchildren's Trust Dated March 9, 2009 10 percent owner C/O BESSEMER TRUST COMPANY OF DELAWARE, 1007 N. ORANGE ST., SUITE 1450, WILMINGTON DE 19801
Joann M Martin director 6221 ANDREW COURT, LINCOLN NE 68512
Helen Hrdy officer: Chief Growth Officer C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Steven D. Jackson officer: President C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
John N Nunnelly director P.O. BOX 2175, AMHERST MA 01004
Barbara Mowry director P.O. BOX 103115, DENVER CO 80250
Michael Hays director, 10 percent owner, officer: President and CEO C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508